How FHG Can Help Retain Your Current Healthcare Customers

Retention starts with clarity and engagement.  Your customers want to know the ROI your solutions deliver to validate a contract renewal. Without a clear picture of current financial value, contract renewals are at risk if the perceived value is not meeting ROI expectations.

FHG creates Customer Retention Assessment Sales Tools designed to:

• Quantify the ROI your solutions are currently delivering
• Highlight the financial value that is lost without continuing to use your solutions
• Equip your Sales Team to address renewal concerns with data-driven confidence

Armed with a Customer Retention Assessment, you strengthen each customer engagement by clearly demonstrating ROI currently being achieved.  This empowers your organization to protect recurring revenue and retain valuable partnerships.

Don’t let perceived value gaps jeopardize renewals.  Partner with FHG to reinforce the ROI of your solutions and turn customer retention conversations into growth opportunities.

Next Steps to Retain Your Current Healthcare Customers:

üSchedule a conversation with FHG

• We want to clearly understand your customer retention strategy
• We want to explore the key financial value drivers of your solutions

1. FHG will design a customized Customer Retention Assessment specific to your solutions
2. FHG will develop a customer-facing presentation to clearly communicate the ROI currently being realized

How FHG Can Help You Generate New Healthcare Business

Customers want to know the ROI they can receive when using your solutions.   Many times, purchasing decisions are based on price, not the financial value generated by your solutions. To differentiate your offering, protect margins, and accelerate sales, you must sell on the ROI, not price. Healthcare organizations face tight budgets and limited resources. That’s why most require a credible ROI analysis when evaluating investment options.

The FiscalHealth Group can help!  We specialize in creating customized Healthcare ROI Assessment Sales Tools tailored to your specific solutions and each unique sales opportunity.  A Healthcare ROI Assessment will help you:

• Demonstrate CFO-credible financial value and ROI that can be achieved with your solutions
• Empower your Sales Team to confidently communicate your ROI with clarity and precision
• Customize each Healthcare ROI Assessment based on customer financial and operational metrics, creating an ROI specific to their organization

The result: a compelling, data-driven ROI sales tool that communicates the Financial Value and ROI your customers can achieve with your solutions.

By partnering with FiscalHealth Group (FHG) and leveraging a Healthcare ROI Assessment, you shift sales conversations from cost to value, closing more deals, protecting margins, and accelerating purchasing decisions.

Next Steps to Generate New Healthcare Business:

üSchedule a conversation with FHG

• We want to clearly understand your solutions and financial value drivers
• We want to discuss how to use a Healthcare ROI Assessment in your sales process

1. FHG will design a customized Healthcare ROI Assessment specific to your solutions
2. FHG will develop a customer-facing sales presentation to clearly communicate the ROI of your solutions

FHG is a nationally recognized expert in modeling the financial impact of lung nodules and lung cancer screening programs.

Our financial models quantify the reimbursement and cost implications of managing lung cancer and nodule patients across a range of screening strategies, helping healthcare organizations manage and treat patients within these programs.

Emerging technologies, particularly Artificial Intelligence (AI), are redefining nodule and lung cancer detection and treatment. AI now plays a transformative role in better identifying high-risk patients, streamlining diagnostic workflows, and influencing clinical decisions throughout the lung cancer care continuum.

In 2024, FHG was honored to support the financial modeling for a landmark study evaluating AI’s use in reading imaging reports and triaging indeterminate pulmonary nodules. This work demonstrated how AI was used to read imaging reports, to detect, and effectively triage indeterminate pulmonary nodules without adding additional personnel, saving lives.

Published in the Annals of Thoracic Surgery (2024;118:712–9), the paper titled, “Artificial Intelligence: Can It Save Lives, Hospitals, and Lung Screening”, © 2024 The Society of Thoracic Surgeons, published by Elsevier Inc., highlights the impact of this innovative approach.

FHG is proud to partner with lung cancer healthcare professionals nationwide, leveraging our deep financial expertise to expand early detection, increase screening rates, and prioritize the evaluation and treatment of incidentally detected nodules (IPN).  As AI transforms clinical care, FHG is ready to quantify its financial impact and accelerate value-driven strategies in lung cancer and nodule detection programs for the treatment of these patients worldwide.